ConductScience.org, home
Papers
API referenceFor AI assistants

Paper75545

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Zamecnik PC and 1 other. Proc Natl Acad Sci U S A, 1978. Cited by 1,372 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Papers, record 75545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75545

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,372
iCite
Relative citation ratio, by iCite
25.6
iCite
Revised in PubMed
2022-03-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zamecnik PCP C
2Stephenson MLM L

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Avian Sarcoma VirusesMajor topic
Cell Transformation, ViralMajor topic
DeoxyribonucleotidesMajor topic
Virus ReplicationMajor topic
Base Sequence
RNA-Directed DNA Polymerase

Source PubMed

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1169,393Plaque assay of avian sarcoma viruses using casein.J Virol1975https://conductscience.org/library/papers/169393PubMed
2171,673Analysis of oncornavirus RNA subunits by electron microscopy.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/171673PubMed
3172,538The use of arylsulfonyltriazoles for the synthesis of oligonucleotides by the triester approach.J Am Chem Soc1975https://conductscience.org/library/papers/172538PubMed
4194,400Characterization of DNA complementary to nucleotide sequences adjacent to poly(A) at the 3'-terminus of the avian sarcoma virus genome.Virology1977https://conductscience.org/library/papers/194400PubMed
5194,401Characterization of DNA complementary to nucleotide sequences at the 5'-terminus of the avian sarcoma virus genome.Virology1977https://conductscience.org/library/papers/194401PubMed
6198,142Avian myeloblastosis virus RNA is terminally redundant: implications for the mechanism of retrovirus replication.Cell1977https://conductscience.org/library/papers/198142PubMed
74,128,377Effects of polyadenylic acids on functions of murine RNA tumor viruses.J Virol1973https://conductscience.org/library/papers/4128377PubMed
84,308,272Rapid transformation of cells by Rous sarcoma virus.Proc Natl Acad Sci U S A1969https://conductscience.org/library/papers/4308272PubMed
94,316,300RNA-dependent DNA polymerase in virions of RNA tumour viruses.Nature1970https://conductscience.org/library/papers/4316300PubMed
104,331,732The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant.Virology1971https://conductscience.org/library/papers/4331732PubMed
114,993,599RNA dependent DNA polymerase activity in mammalian cells.Nature1971https://conductscience.org/library/papers/4993599PubMed
125,032,958Studies on polynucleotides. CII. The use of aromatic isocyanates for selective blocking of the terminal 3'-hydroxyl group in protected deoxyribooligonucleotides.J Am Chem Soc1972https://conductscience.org/library/papers/5032958PubMed
13557,989Effects of a trinucleotide ethyl phosphotriester, Gmp(Et)Gmp(Et)U, on mammalian cells in culture.Biochemistry1977https://conductscience.org/library/papers/557989PubMed
1466,683Rous sarcoma virus genome is terminally redundant: the 5' sequence.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/66683PubMed
1566,684Rous sarcoma virus genome is terminally redundant: the 3' sequence.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/66684PubMed
1667,601Nucleotide sequence at the 5' terminus of the avian sarcoma virus genome.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/67601PubMed
1768,472Terminal redundancy and the origin of replication of Rous sarcoma virus RNA.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/68472PubMed
1870,037Terminally repeated sequences in the avian sarcoma virus RNA genome.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/70037PubMed
1975,546Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/75546PubMed

Cited by503

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,372 citations.

PMIDTitleJournalYearIn PapersSource
42,890,029From a Concept on a Chalkboard to Gapmer Antisense.ACS Omega2026https://conductscience.org/library/papers/42890029PubMed
42,818,544Cap-Independent Translation Regulation of VEGF Using CRISPR-dCas13d.bioRxiv2026https://conductscience.org/library/papers/42818544PubMed
42,814,310Viral RNA-Targeting Locked Nucleic Acid Gapmers: Design and In Vitro Evaluation.Methods Mol Biol2026https://conductscience.org/library/papers/42814310PubMed
42,814,294Gapmers: Invention and Early History.Methods Mol Biol2026https://conductscience.org/library/papers/42814294PubMed
42,797,364Small Nucleic Acid Therapeutics for Ocular Diseases: Progress, Challenges, and Future Perspectives.Pharmaceutics2026https://conductscience.org/library/papers/42797364PubMed
42,786,162RNA therapeutics: current status and future directions.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42786162PubMed
42,772,282Therapeutic oligonucleotides as genetic medicines: The current state and future perspective.Cell Rep Med2026https://conductscience.org/library/papers/42772282PubMed
42,588,437Chemical Modification Strategies for Therapeutic Oligonucleotides: Mechanism Compatibility, Design Trade-Offs, and Translational Barriers.Molecules2026https://conductscience.org/library/papers/42588437PubMed
42,542,598Accurately modeling RNase H-mediated antisense oligonucleotide efficacy.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42542598PubMed
42,514,871Analytical Characterization and Stability Assessment of RNA-Based Vaccines.Pharmaceutics2026https://conductscience.org/library/papers/42514871PubMed
42,503,038Nucleobase Amino Acids in the Development of Amide-Linked Oligonucleotide Mimics.ChemMedChem2026https://conductscience.org/library/papers/42503038PubMed
42,453,399In vitro transcribed circRNA as a therapeutic agent for cancer.Acta Pharm Sin B2026https://conductscience.org/library/papers/42453399PubMed
42,389,201RNApedia: a database of structural protein-RNA interactions.Front Bioinform2026https://conductscience.org/library/papers/42389201PubMed
42,380,588Advancements in RNA-based therapies from bench to bedside.NPJ Drug Discov2026https://conductscience.org/library/papers/42380588PubMed
42,350,624The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.Cell Death Differ2026https://conductscience.org/library/papers/42350624PubMed
42,332,368Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-BrainshuttleTM variants.MAbs2026https://conductscience.org/library/papers/42332368PubMed
42,322,227Synthesis of Oligonucleotide Conjugates Employing a Diselenide Linker.Chemistry2026https://conductscience.org/library/papers/42322227PubMed
42,239,496Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42239496PubMed
42,222,275RNA therapeutic targeting of recalcitrant and rare cancers.Explor Target Antitumor Ther2026https://conductscience.org/library/papers/42222275PubMed
42,180,980Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategies.Transl Cancer Res2026https://conductscience.org/library/papers/42180980PubMed

See all 503 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/75545

GET https://conductscience.org/api/papers/v1/75545/cited_by?page=2

API referenceFor AI assistants